These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 29143160)

  • 21. Hybrid imidazole (benzimidazole)/pyridine (quinoline) derivatives and evaluation of their anticancer and antimycobacterial activity.
    Mantu D; Antoci V; Moldoveanu C; Zbancioc G; Mangalagiu II
    J Enzyme Inhib Med Chem; 2016; 31(sup2):96-103. PubMed ID: 27250919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, tautomeric structures, and antitumor activity of new perimidines.
    Farghaly TA; Mahmoud HK
    Arch Pharm (Weinheim); 2013 May; 346(5):392-402. PubMed ID: 23553920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and characterization of 2-substituted benzimidazoles and their evaluation as anticancer agent.
    Azam M; Khan AA; Al-Resayes SI; Islam MS; Saxena AK; Dwivedi S; Musarrat J; Trzesowska-Kruszynska A; Kruszynski R
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 May; 142():286-91. PubMed ID: 25706598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antioxidative and antiproliferative activities of novel pyrido[1,2-a]benzimidazoles.
    Tireli M; Starčević K; Martinović T; Pavelić SK; Karminski-Zamola G; Hranjec M
    Mol Divers; 2017 Feb; 21(1):201-210. PubMed ID: 27677735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and antitumor activity of novel quinazoline derivatives containing thiosemicarbazide moiety.
    He J; Wang X; Zhao X; Liang Y; He H; Fu L
    Eur J Med Chem; 2012 Aug; 54():925-30. PubMed ID: 22749192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, anticancer activity and UPLC analysis of the stability of some new benzimidazole-4,7-dione derivatives.
    Błaszczak-Swiatkiewicz K; Almeida DC; De Jesus Perry M; Mikiciuk-Olasik E
    Molecules; 2013 Dec; 19(1):400-13. PubMed ID: 24384922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biological evaluation of novel 2-(2-arylmethylene)hydrazinyl-4-aminoquinazoline derivatives as potent antitumor agents.
    Jiang N; Zhai X; Zhao Y; Liu Y; Qi B; Tao H; Gong P
    Eur J Med Chem; 2012 Aug; 54():534-41. PubMed ID: 22727449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential anti-cancer agents.
    Alafeefy AM; Ashour AE
    J Enzyme Inhib Med Chem; 2012 Aug; 27(4):541-5. PubMed ID: 21851213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, characterization and biological evaluation of some 16β-azolyl-3β-amino-5α-androstane derivatives as potential anticancer agents.
    Guo H; Zhang G; Zhang T; He X; Wu Z; Xiao Y; Pan Y; Qiu G; Liu P; Hu X
    Eur J Med Chem; 2011 Sep; 46(9):3662-74. PubMed ID: 21641694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis and biological evaluation of novel benzimidazole-2-substituted phenyl or pyridine propyl ketene derivatives as antitumour agents.
    Wu LT; Jiang Z; Shen JJ; Yi H; Zhan YC; Sha MQ; Wang Z; Xue ST; Li ZR
    Eur J Med Chem; 2016 May; 114():328-36. PubMed ID: 27017265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular docking simulation, synthesis and 3D pharmacophore studies of novel 2-substituted-5-nitro-benzimidazole derivatives as anticancer agents targeting VEGFR-2 and c-Met.
    Ibrahim HA; Awadallah FM; Refaat HM; Amin KM
    Bioorg Chem; 2018 Apr; 77():457-470. PubMed ID: 29453077
    [No Abstract]   [Full Text] [Related]  

  • 32. Synthesis, DNA binding ability and anticancer activity of 2-heteroaryl substituted benzimidazoles linked pyrrolo[2,1-c][1,4]benzodiazepine conjugates.
    Kamal A; Pogula PK; Khan MN; Seshadri BN; Sreekanth K
    Med Chem; 2013 Aug; 9(5):651-9. PubMed ID: 23301523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and molecular modeling of new benzimidazoles as glutathione S-transferase inhibitors and anticancer agents.
    Abd El-Karim SS; Anwar MM; Zaki ER; Elseginy SA; Nofal ZM
    Future Med Chem; 2018 Jan; 10(2):157-181. PubMed ID: 29235906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and antiproliferative activity of some benzimidazole-4,7-dione derivatives.
    Garuti L; Roberti M; Malagoli M; Rossi T; Castelli M
    Bioorg Med Chem Lett; 2000 Oct; 10(19):2193-5. PubMed ID: 11012027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis and in vitro antitumor evaluation of novel pyrazole-benzimidazole derivatives.
    Ren B; Liu RC; Ji K; Tang JJ; Gao JM
    Bioorg Med Chem Lett; 2021 Jul; 43():128097. PubMed ID: 33979690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological evaluation of novel pyrimidine-benzimidazol hybrids as potential anticancer agents.
    Shao KP; Zhang XY; Chen PJ; Xue DQ; He P; Ma LY; Zheng JX; Zhang QR; Liu HM
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3877-81. PubMed ID: 25001482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of amidine and bis amidine derivatives and their evaluation for anti-inflammatory and anticancer activity.
    Arya S; Kumar N; Roy P; Sondhi SM
    Eur J Med Chem; 2013 Jan; 59():7-14. PubMed ID: 23202484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benzimidazole Scaffold as Anticancer Agent: Synthetic Approaches and Structure-Activity Relationship.
    Shrivastava N; Naim MJ; Alam MJ; Nawaz F; Ahmed S; Alam O
    Arch Pharm (Weinheim); 2017 Jun; 350(6):. PubMed ID: 28544162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
    Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI
    Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and biological evaluation of novel benzimidazole amidines as potent multi-target inhibitors for the treatment of non-small cell lung cancer.
    Bistrović A; Krstulović L; Harej A; Grbčić P; Sedić M; Koštrun S; Pavelić SK; Bajić M; Raić-Malić S
    Eur J Med Chem; 2018 Jan; 143():1616-1634. PubMed ID: 29133046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.